The Editors of the JPST Thank the Outstanding Peer Reviewers of 2022
The editors and the PDA community want to extend their appreciation of the peer reviewers who played an integral role in producing the JPST each year. For 2022, nearly 120 experts participated in the PDA JPST peer review process, ensuring each manuscript published met the high standards expected by our community of authors and readers. We always need peer reviewers. If you are a published contributor to the JPST, we likely will call on you to serve as a peer reviewer in the future. Therefore, it is important that you update your record in the submission system to include your area(s) of expertise. Then, the editors can choose you to review one or two papers each year. More information on being a reviewer can be found here.
Click here for the complete list of 2022 reviewers, published in the Jan-Feb 2023 issue.
Accepted Articles
Featured Articles
PDA President Richard Johnson's Farewell
President Richard Johnson's Farewell to PDA
This message will be my last to you as the President of PDA. After 13+ years as President, I will be retiring March 1, 2023. I joined PDA as President in the firm belief that PDA is an important resource for our community. As I look back on this period, I am reminded of all the things that this organization has accomplished since 2009. Strategy Over the past 13 years, I have participated in the development of three strategic plans, all of them furthering the focus on “connecting people, science and regulation.” Proudly, I must say that we have accomplished many of our goals while continuing to pursue others. Since then, we have updated our mission: to advance pharmaceutical/ biopharmaceutical manufacturing science and regulation so members can better serve patients. Our values are published, which include “science based, integrity and Inclusion.” These things constantly guide our activities.
